Helen Sabzevari - 24 Jun 2021 Form 3 Insider Report for Kinnate Biopharma Inc.

Role
Director
Signature
/s/ Mark A. Meltz, attorney-in-fact
Issuer symbol
N/A
Transactions as of
24 Jun 2021
Net transactions value
$0
Form type
3
Filing time
28 Jun 2021, 13:02:22 UTC
Previous filing
14 May 2021
Next filing
20 Jul 2021

No securities are beneficially owned.